ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023)
ENDRA Life Sciences' (NDRA) quarterly Short term Debt came in at $28484.0 in Q4 2023, little changed year-over-year from $28484.0 in Q4 2022, and little changed quarter-over-quarter from $28484.0 in Q3 2023.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Short term Debt for 2 consecutive years, with $28484.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Short term Debt changed 0.0% year-over-year to $28484.0 in Q4 2023; TTM through Dec 2023 was $28484.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $28484.0, changed 0.0% from the prior year.
- Short term Debt was $28484.0 for Q4 2023 at ENDRA Life Sciences, roughly flat from $28484.0 in the prior quarter.
- Over five years, Short term Debt peaked at $28484.0 in Q4 2022 and troughed at $28484.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 28,484.00 |
| Sep 30, 2023 | 28,484.00 |
| Jun 30, 2023 | 28,484.00 |
| Dec 31, 2022 | 28,484.00 |